Dual energy computed tomography for detection of metastatic lymph nodes in patients with hepatocellular carcinoma.

Yu-Rong Zeng, Qi-Hua Yang, Qing-Yu Liu, Jun Min, Hai-Gang Li, Zhi-Feng Liu, Ji-Xin Li
Author Information
  1. Yu-Rong Zeng: Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.
  2. Qi-Hua Yang: Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.
  3. Qing-Yu Liu: Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China. liuqy@mail.sysu.edu.cn.
  4. Jun Min: Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.
  5. Hai-Gang Li: Department of Pathology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.
  6. Zhi-Feng Liu: Department of Radiology, Zengcheng District People's Hospital of Guangzhou, Guangzhou 511300, Guangdong Province, China.
  7. Ji-Xin Li: Department of Radiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, Guangdong Province, China.

Abstract

BACKGROUND: Regional lymph node metastasis in patients with hepatocellular carcinoma (HCC) is not uncommon, and is often under- or misdiagnosed. Regional lymph node metastasis is associated with a negative prognosis in patients with HCC, and surgical resection of lymph node metastasis is considered feasible and efficacious in improving the survival and prognosis. It is critical to characterize lymph node preoperatively. There is currently no consensus regarding the optimal method for the assessment of regional lymph nodes in patients with HCC.
AIM: To evaluate the diagnostic value of single source dual energy computed tomography (CT) in regional lymph node assessment for HCC patients.
METHODS: Forty-three patients with pathologically confirmed HCC who underwent partial hepatectomy with lymphadenectomy were retrospectively enrolled. All patients underwent dual-energy CT preoperatively. Regional lymph nodes ( = 156) were divided into either a metastatic (group , = 52) or a non-metastasis group (group , = 104), and further, according to pathology, divided into an active hepatitis (group , = 34; group , = 73) and a non-active hepatitis group (group , = 18; group , = 31). The maximal short axis diameter (MSAD), iodine concentration (IC), normalized IC (NIC), and the slope of the spectral curve ( ) of each group in the arterial phase (AP), portal phase (PP), and delayed phase (DP) were analyzed.
RESULTS: Analysis of the MSAD, IC, NIC, and showed statistical differences between groups and ( < 0.05) during all three phases. To distinguish benign from metastatic lymph nodes, the diagnostic efficacy of IC, NIC, and in the PP was the best among the three phases (AP, PP, and DP), with a sensitivity up to 81.9%, 83.9%, and 81.8%, and a specificity up to 82.4%, 84.1% and 84.1%, respectively. The diagnostic value of combined analyses of MSAD with IC, NIC, or in the PP was superior to the dual energy CT parameters alone, with a sensitivity up to 84.5%, 86.9%, and 86.2%, and a specificity up to 83.0%, 93.6% and 89.8%, respectively. Between groups and and groups and , only IC, NIC, and between groups and in the PP had a statistically significant difference ( < 0.05).
CONCLUSION: Dual-energy CT contributes beneficially to regional lymph node assessment in HCC patients. Combination of MSAD with IC, NIC, or values in the PP is superior to using any single parameter alone. Active hepatitis does not deteriorate the capabilities for characterization of metastatic lymph nodes.

Keywords

References

  1. Ann Surg. 2006 Aug;244(2):260-4 [PMID: 16858189]
  2. J Nucl Med. 2007 Jun;48(6):902-9 [PMID: 17504862]
  3. J Am Coll Surg. 2007 Jul;205(1):108-23 [PMID: 17617340]
  4. J Nucl Med. 2008 Jul;49(7):1053-9 [PMID: 18587087]
  5. Hepatogastroenterology. 2009 May-Jun;56(91-92):788-92 [PMID: 19621703]
  6. World J Surg. 2010 May;34(5):1028-33 [PMID: 20174806]
  7. Gan To Kagaku Ryoho. 2010 Apr;37(4):582-6 [PMID: 20414011]
  8. J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):559-66 [PMID: 21331804]
  9. World J Gastroenterol. 2012 Jun 21;18(23):2979-87 [PMID: 22736922]
  10. Nucl Med Commun. 2013 Aug;34(8):749-57 [PMID: 23689586]
  11. World J Radiol. 2013 May 28;5(5):208-14 [PMID: 23805371]
  12. Eur Radiol. 2014 Mar;24(3):574-80 [PMID: 24081649]
  13. PLoS One. 2014 Apr 23;9(4):e95889 [PMID: 24760012]
  14. Radiology. 2014 May;271(2):327-42 [PMID: 24761954]
  15. Eur Radiol. 2014 Aug;24(8):1981-8 [PMID: 24895031]
  16. Nucl Med Mol Imaging. 2012 Sep;46(3):189-95 [PMID: 24900059]
  17. Surg Today. 2015 Sep;45(9):1112-20 [PMID: 25205550]
  18. J Clin Gastroenterol. 2015 Jul;49(6):520-8 [PMID: 25564411]
  19. Acta Otolaryngol. 2015 Jul;135(7):722-8 [PMID: 25719763]
  20. Clin Imaging. 2015 Sep-Oct;39(5):856-62 [PMID: 26091745]
  21. Ann Nucl Med. 2016 Feb;30(2):104-13 [PMID: 26546334]
  22. J Ultrason. 2015 Jun;15(61):137-50 [PMID: 26676184]
  23. Dis Colon Rectum. 2016 Jul;59(7):640-7 [PMID: 27270516]
  24. Semin Roentgenol. 2016 Oct;51(4):284-291 [PMID: 27743564]
  25. Eur J Radiol. 2017 May;90:81-88 [PMID: 28583651]
  26. Eur Radiol. 2018 Feb;28(2):760-769 [PMID: 28835993]

MeSH Term

Carcinoma, Hepatocellular
Contrast Media
Female
Hepatectomy
Humans
Image Processing, Computer-Assisted
Liver Neoplasms
Lymph Nodes
Lymphatic Metastasis
Male
Middle Aged
ROC Curve
Retrospective Studies
Tomography, X-Ray Computed

Chemicals

Contrast Media

Word Cloud

Created with Highcharts 10.0.0lymphgrouppatientsnode=ICHCCNICPPnodesenergyCTmetastaticMSADgroupsRegionalmetastasiscarcinomaassessmentregionaldiagnostictomographyhepatitisphase9%84hepatocellularprognosispreoperativelyvaluesingledualcomputedunderwentdividedAPDP<005threephasessensitivity81838%specificity1%respectivelysuperioralone86DualBACKGROUND:uncommonoftenunder-misdiagnosedassociatednegativesurgicalresectionconsideredfeasibleefficaciousimprovingsurvivalcriticalcharacterizecurrentlyconsensusregardingoptimalmethodAIM:evaluatesourceMETHODS:Forty-threepathologicallyconfirmedpartialhepatectomylymphadenectomyretrospectivelyenrolleddual-energy156either52non-metastasis104accordingpathologyactive3473non-active1831maximalshortaxisdiameteriodineconcentrationnormalizedslopespectralcurvearterialportaldelayedanalyzedRESULTS:Analysisshowedstatisticaldifferencesdistinguishbenignefficacybestamong824%combinedanalysesparameters5%2%0%936%89statisticallysignificantdifferenceCONCLUSION:Dual-energycontributesbeneficiallyCombinationvaluesusingparameterActivedeterioratecapabilitiescharacterizationdetectionComputedHepatitisHepatocellularLymphMetastasis

Similar Articles

Cited By